Operating

Change in AR

United Therapeutics Change in AR decreased by 172.8% to -$38.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 189.5%, from $42.70M to -$38.20M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

A decrease is generally positive as it indicates faster collection of cash from customers.

Detailed definition

This measures the change in the amount of money owed to the company by customers for goods or services delivered on cred...

Peer comparison

Standard metric for all companies; peers in medical devices monitor this closely to manage working capital cycles.

Metric ID: change_in_accounts_receivable

Historical Data

17 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$32.40M$39.30M-$28.10M$2.80M$58.30M-$85.90M$138.10M-$14.00M$20.30M$28.30M-$16.50M$51.10M$42.70M$57.30M-$81.60M$52.50M-$38.20M
QoQ Change+21.3%-171.5%+110.0%>999%-247.3%+260.8%-110.1%+245.0%+39.4%-158.3%+409.7%-16.4%+34.2%-242.4%+164.3%-172.8%
YoY Change-91.4%+48.3%-205.7%>999%-124.0%+132.9%-111.9%+465.0%+50.9%+447.3%-259.7%-189.5%
Range-$85.90M$138.10M
CAGR+4.2%
Avg YoY Growth+416.2%
Median YoY Growth-21.5%

Frequently Asked Questions

What is United Therapeutics's change in ar?
United Therapeutics (UTHR) reported change in ar of -$38.20M in Q1 2026.
How has United Therapeutics's change in ar changed year-over-year?
United Therapeutics's change in ar decreased by 189.5% year-over-year, from $42.70M to -$38.20M.
What does change in ar mean?
The change in money owed to the company by customers for past sales.